Miklos Z. Molnar
· Professor (Clinical)University of Utah · Nephrology
Active 1966–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Dr. Miklos Z. Molnar is a Professor of Medicine and the Medical Director of the Kidney and Pancreas Transplantation Programs and Living Donor Transplantation Program at the University of Utah Hospital and Clinics. He is also the Director of the Kidney Clinics. Dr. Molnar obtained his M.D. and Ph.D. from Semmelweis University in Budapest, Hungary. After completing his residency and fellowship in Europe, he immigrated to the USA in 2010. He completed his residency in Internal Medicine and received specialized training and faculty experience as a transplant nephrologist at the University of Tennessee Health Science Center in Memphis, TN, following his nephrology fellowship at the University of Toronto, Ontario, Canada. He is board certified in Internal Medicine and Nephrology, with additional certifications in Transplant Medicine from Europe. His primary clinical interests involve all aspects of kidney transplantation, including candidate evaluation for recipients and living donors, organ procurement processes, perioperative care, and long-term management of transplant recipients and donors. His clinical expertise also extends to pancreas transplant evaluation and care, as well as the prevention, diagnosis, and treatment of native kidney diseases and acute kidney injury. Dr. Molnar's primary research interests focus on outcome research in kidney transplant recipients. He is active in clinical research, frequently presents at national and international meetings, and has authored…
Research topics
- Medicine
- Internal medicine
- Intensive care medicine
- Virology
- Urology
- Immunology
- Endocrinology
- Gastroenterology
- Pathology
- Family medicine
Selected publications
Annals of Internal Medicine · 2021 · 140 citations
BACKGROUND: Hypercoagulability may be a key mechanism of death in patients with coronavirus disease 2019 (COVID-19). OBJECTIVE: To evaluate the incidence of venous thromboembolism (VTE) and major bleeding in critically ill patients with COVID-19 and examine the observational effect of early therapeutic anticoagulation on survival. DESIGN: In a multicenter cohort study of 3239 critically ill adults with COVID-19, the incidence of VTE and major bleeding within 14 days after intensive care unit (IC…
Renal Failure · 2025-01-21 · 10 citations
articleOpen accessPredicting the outcome of a kidney transplant involving a living donor advances donor decision-making donors for clinicians and patients. However, the discriminative or calibration capacity of the currently employed models are limited. We set out to apply artificial intelligence (AI) algorithms to create a highly predictive risk stratification indicator, applicable to the UK's transplant selection process. Pre-transplant characteristics from 12,661 live-donor kidney transplants (performed betwee…
Renal Failure · 2024-10-22 · 9 citations
articleOpen accessk-means clustering was employed to identify five distinct clusters based on donor and transplant characteristics, uncovering nuanced insights into graft survival outcomes. These clusters were further analyzed using Bayesian Cox regression, which confirmed significant survival outcome variations across the clusters, thereby validating the model's effectiveness in enhancing risk stratification. The UK-DTOP tool offers a comprehensive decision-support system that significantly refines pre-transplan…
Clinical Journal of the American Society of Nephrology · 2023 · 8 citations
Senior authorCorrespondingBACKGROUND: Acceptable post-transplant outcomes were reported in kidney transplant recipients from donors with coronavirus disease 2019 (COVID-19); however, there are no comparative studies with well-matched controls. METHODS: This multicenter, prospective observational study, which included three transplant centers in the United States, enrolled 61 kidney recipients from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected deceased donors. Using optimal matching methods, we mat…
Transplantation · 2024 · 6 citations
Senior authorCorrespondingBACKGROUND: It is unclear whether kidney grafts from deceased donors with acute kidney injury (AKI) are more vulnerable to calcineurin inhibitor nephrotoxicity, and whether de novo use of belatacept is more beneficial than tacrolimus for recipients of these types of kidney transplants. METHODS: In this retrospective cohort study using the US Organ Procurement and Transplantation Network database, we created 1:4 matches with highly similar characteristics for recipients of AKI-donor kidneys recei…
Recent grants
NIH · $424k · 2017
Frequent coauthors
- 1059 shared
Kamyar Kalantar‐Zadeh
UCLA Medical Center
- 881 shared
Csaba P. Kövesdy
University of Tennessee Health Science Center
- 392 shared
Elani Streja
University of California, Irvine
- 383 shared
István Mucsi
University Health Network
- 260 shared
Márta Novák
- 177 shared
Manish Talwar
- 175 shared
Masahiko Yazawa
St. Marianna University School of Medicine
- 171 shared
Vasanthi Balaraman
Education
M.D.
Semmelweis University
Ph.D.
Semmelweis University
Other, Transplant Nephrology
University of Tennessee Health Science Center
Other, Nephrology
University of Toronto
Similar researchers at University of Utah
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Miklos Z. Molnar
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup